CL
JSPR icon

CSS LLC’s Jasper Therapeutics JSPR Stock Holding History

CSS LLC’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,010
Closed -$13.8K – 873
2023
Q2 		$13.8K Hold
1,010
– – ﹤0.01% 832
2023
Q1 		$18.3K Buy
+1,010
New +$18.7K ﹤0.01% 646

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CSS LLC's JSPR Position: Q1 2021 in Review

CSS LLC sold out of Jasper Therapeutics (JSPR) in Q1 2021, closing a stake of 5,483 shares — an estimated $549K sold.

CSS LLC first reported a position in JSPR in Q4 2020 and held it in 1 quarter. The position peaked at $549K in Q4 2020. 53 funds tracked by Wall St. Rank hold JSPR as of Q1 2021.

  • CSS LLC reported no remaining Jasper Therapeutics position as of Q1 2021 after selling out during the quarter.
  • CSS LLC sold 5,483 Jasper Therapeutics shares in Q1 2021, an estimated $549K.
  • CSS LLC first reported a position in Jasper Therapeutics in Q4 2020 and held it in 1 quarter.
  • CSS LLC's Jasper Therapeutics position peaked at $549K in Q4 2020.
  • 53 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q1 2021.

Based on CSS LLC's 13F filing for Q1 2021, filed 17 May 2021.